Where is this company's market in its cycle, and what does that phase mean for it?
Alleima sits in a downcycle: organic revenue fell 2 percent during the quarter as weak OCTG demand and a cooling in the Chinese chemical and petrochemical market that had previously been strong weighed on the top line, while low OCTG volumes lifted under-absorption and the nuclear business dragged on a production rate below plan. More than eight months of crisis in the Middle East and a largely stalled OCTG market left the oil and gas segment of the Tube division increasingly hurt.
The Kanthal division posted another strong quarter of profitable growth, powered by electric-heating demand from electronics and semiconductor makers and by medical products such as diabetes treatments. During the quarter Alleima also announced a SEK 220 million investment at its Mehsana, India facility to expand further processing and finishing capacity and strengthen its position in segments including chemical and petrochemical.
What could change its growth trajectory, and what would confirm it?
Alleima's growth is coming from nuclear, industrial heating, and medical demand even as total organic revenue declines. After the quarter ended, the company received several orders in the Nuclear segment across multiple product categories, and the Industrial Heating and Medical segments continued to develop positively. Quarterly revenues amounted to SEK 4,257 million, with organic growth of negative 2 percent, affected by continued weak OCTG business and a slowdown in the previously strong Chinese chemical and petrochemical market.
During the quarter, Alleima announced a SEK 220 million investment at its production facility in Mehsana, India, which increases capacity for further processing and finishing and strengthens its position in segments including Chemical and Petrochemical. In December, Alleima agreed to acquire Endox Feinwerktechnik, a German medical component manufacturer. In 2022, Alleima acquired the tube engineering solutions company Gerling Metallverarbeitung, strengthening its offering and capabilities in the fast-developing hydrogen market.
Which risks could break the thesis, and what would warn of them?
Alleima's near-term risk sits outside its own operations, in a customer's cancellation of an approximately SEK 250 million order scheduled for fourth-quarter 2026 production and in trade policy. The cancelled order was reported as negative order intake during the quarter, and because Alleima both sells to and manufactures in the US, import tariffs affect it directly and indirectly, leaving the future impact on earnings and financial position hard to foresee amid prevailing uncertainty.
Alleima has direct exposure to the Middle East through customers, supply chains and logistics flows, but maintains no operations or sales in Iran. Adjusted EBIT reached SEK 40 million at a 1.4 percent margin, primarily hurt by under-absorption effects in Oil and Gas and temporary production challenges in Nuclear, mainly because project-business timing pushed several orders into October.

Alleima is an advanced materials technology company making stainless tubes and strip steel, plus fine wire.